These findings suggest that miR-153/Nrf-2/GPx1 pathway play a important role in regulating radiosensitivity and stemness of GSCs via ROS and targeting the miR-153/Nrf-2/GPx1 axis could be a novel approach in development of therapeutic strategies against glioma. The gene discussed is NFE2L2; the disease is central nervous system cancer.